Merck Enters Share Repurchase Agreement With Goldman Sachs

As part of an overall stock buyback scheme, Merck (NYSE: MRK  ) has launched an accelerated repurchase program to buy shares held by Goldman Sachs (NYSE: GS  ) . All told, the pharmaceutical company will purchase $5 billion worth of its stock from the investment bank.

That figure equates to roughly 99.5 million shares. The transaction is expected to be completed by Nov. 25 of this year.

Merck has been quite busy in the stock buyback sphere of late. As of April 30, the firm's total outstanding authorization for such activity stood at $16.1 billion. In the first four months of this year, it bought back around 17.8 million shares, spending $772 million to do so.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2445634, ~/Articles/ArticleHandler.aspx, 11/21/2014 3:44:40 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement